Preview

General Reanimatology

Advanced search

Role of Early Immune Replacement Therapy in Reducing the Rate of Nosocomial Pneumonia in Severe Polytrauma

https://doi.org/10.15360/1813-9779-2014-6-15-23

Abstract

Objective: to evaluate the efficiency of early immune replacement therapy (EIRT) in patients with severe polytrauma (SCI).

Subjects and methods. Two hundred and twentyfive victims aged 35.5±14.1 years with SCI (ISS>30 scores), including 158 cases of nosocomial pneumonia, were examined. According to the use of EIRT with donor immunoglobulin (IgG) (daily within the first three days), the patients were divided into two groups: 1) standard intensive treatment was added by EIRT (n=126) and 2) that without EIRT (n=99). Immunological examination was performed on days 1, 3, 6, and 9 after injury. The investigators determined the relative and absolute counts of major lymphocyte populations: T (CD3+) and B (CD19+) lymphocytes, those of T cell populations: (CD4+) helper T cells and (CD8+) cytotoxic T lymphocytes, the concentrations of the immunoglobulins A, O, and M classes (IgA, IgG and IgM), neutrophil absorptive and bactericidal activ
ities, and the serum levels of large, middle, and small circulating immune complexes, Creactive protein, and procalcitonin. The incidence of nosocomial pneumonia and sepsis and the outcome of injury were analyzed in both groups.

Results. The performed investigation indicated that EIRT in Group 1 victims resulted in a 27.6% decline in the number of patients who had received mechanical ventilation (MV) for more than 3 days and reduced the rate of earlyonset pneumonia and sepsis by 24.3 and 5.2%, respectively, and the intensive care unit length of stay from 20.2 to 12.5 days, mortality rates by 12.1%, and deaths by 1%.

Conclusion. EIRT used to treat victims with SCI could decrease the duration of MV and the incidence of nosocomial pneumonia, which in turn reduced mortality rates in the examined groups.

About the Authors

A. K. Shabanov
N. V. Sklifosovsky Research Institute of Emergency Care, Moscow, Russia 3, B. Sukharevskaya Sq., Moscow 129010
Russian Federation


G. V. Bulava
N. V. Sklifosovsky Research Institute of Emergency Care, Moscow, Russia 3, B. Sukharevskaya Sq., Moscow 129010
Russian Federation


M. V. Androsova
N. V. Sklifosovsky Research Institute of Emergency Care, Moscow, Russia 3, B. Sukharevskaya Sq., Moscow 129010
Russian Federation


A. N. Kuzovlev
V. A. Negovsky Research Institute of General Reanimatology, Moscow, Russia 25, Petrovka, Build. 2, Moscow 107031
Russian Federation


E. V. Kislukhina
N. V. Sklifosovsky Research Institute of Emergency Care, Moscow, Russia 3, B. Sukharevskaya Sq., Moscow 129010
Russian Federation


M. Sh. Khubutia
N. V. Sklifosovsky Research Institute of Emergency Care, Moscow, Russia 3, B. Sukharevskaya Sq., Moscow 129010
Russian Federation


References

1. Moroz V.V., Kuzovlev A.N., Polovnikov S.G., Stets V.V., Varvarin V.V. Ingalyatsionnyi tobramitsin v lechenii tyazhelykh nozokomialnykh pnevmonii. Obshchaya Reanimatologiya. [Inhaled tobramycin in the treatment of severe nosocomial pneumonias. General Reanimatology]. 2012; 8 (2): 5–10. http://dx.doi.org/10.15360/18139779201225. [In Russ.]

2. Kuzovlev A.N., Moroz V.V., Golubev A.M., Polovnikov S.G. Ingalyatsionnye antibiotiki v lechenii nozokomialnoi pnevmonii. Obshchaya Reanimatologiya. [Inhaled antibiotics in the treatment of nosocomial pneumonia. General Reanimatology]. 2013; 9 (6): 61–70. http://dx.doi.org/10.15360/181397792013661. [In Russ.]

3. Yakovlev A.Yu., Gushchina N.N., Niyazmatov A.A., Zaitsev R.M., Golubtsova E.Yu., Ryabikova M.A. Rannyaya otsenka effektivnosti antibakterialnoi terapii nozokomialnoi pnevmonii putem kolichestvenno go opredeleniya lipopolisakharida. Obshchaya Reanimatologiya. [Early evaluation of the efficiency of antibiotic therapy for by quantifying lipopolysaccharide. General Reanimatology]. 2013; 9 (6): 45–52. http://dx.doi.org/10.15360/181397792013645. [In Russ.]

4. Kollef M.H. Prevention of hospitalassociated pneumonia and ventila torassociated pneumonia. Crit. Care Med. 2004; 32 (6): 1396–1405. http://dx.doi.org/10.1097/01.CCM.0000128569.09113.FB. PMID: 15187525

5. Ermolov A.S., Abakumov M.M., Sokolov V.A., Kartavenko V.I., Galankina I.E., Garaev D.A. Struktura gospitalnoi letalnosti pri sochetannoi travme i puti ee snizheniya. [Structure of hospital lethality in poly trauma and ways to reduce it]. Khirurgiya. Zhurnal Imeni N.I.Pirogova. 2006; 9: 16–20. PMID: 17047627. [In Russ.]

6. Khubutiya M.Sh., Shabanov A.K. Osnovnye prichiny letalnosti u postradavshikh s tyazheloi sochetannoi travmoi v otdelenii reanimat sii. [Main mortality reasons at patients with severe polytrauma in the intensive care unit]. Skoraya Meditsinskaya Pomoshch. 2010; 11 (3): 64–69. [In Russ.]

7. Egorova N.I., Vlasenko A.V., Moroz V.V., Yakovlev V.N., Alekseyev V.G. Ventilyatorassotsiirovannaya pnevmoniya: diagnostika, profilaktika, lechenie (sovremennoe sostoyanie voprosa). Obshchaya eanimatologiya. [Ventilatorassociated pneumonia; diagnosis, prevention, treatment (stateoftheart of the problem). General Reanimatology]. 2010; 6 (1): 79–88. http://dx.doi.org/10.15360/181397792010179. [In Russ.]

8. Gumanenko E.K., Ogarkov P.I., Lebedev V.F., Boyarintsev V.V., Kuzin A.A. Infektsionnye oslozhneniya politravm: mikrobiologicheskie i epidemiologicheskie aspekty. [Infectious complications of polytraumas: microbiological and epidemiological aspects]. Vestnik Khirurgii Imeni I.I.Grekova. 2006; 165 (5): 56–62. PMID: 17315690. [In Russ.]

9. Pivovarova L.P., Ariskina O.B., Kladukhina N.A. Immunologicheskie kriterii infektsionnykh oslozhnenii pri tyazheloi mekhanicheskoi travme. V kn.: Sochetannaya i mnozhestvennaya travma. Sbornik nauchnykh trudov. [Immunological criteria for infectious complications of severe mechanical injury. In: Concomitant and multiple mechanical injury. Collection of scientific papers]. Sankt Peterburg; 1997: 127–141. [In Russ.]

10. Abakumov M.M., Bulava G.V. Povrezhdeniya grudi, zhivota i immunnaya sistema. [Thoracic and abdominal injuries and the immune system]. Moscow: STROM; 2006: 171. [In Russ.]

11. Bulava G.V., Nikitina O.V., Dorfman A.G., Manykin I.E. Opyt primeneniya pentaglobina pri travme grudi i zhivota s massivnoi krovopoterei. [Experience with pentaglobin used in thoracic and abdominal injuries with massive blood loss]. Vestnik Intensivnoi Terapii. 2006; 4: 3–6. [In Russ.]

12. Chuchalin A.G. (red.). Nozokomialnaya pnevmoniya u vzroslykh. Natsionalnye rekomendatsii. [Adultonset pneumonia. National guide lines]. Moscow; 2009. [In Russ.]

13. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., Cohen J., Opal S.M., Vincent J.L., Ramsay G.; SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 2003; 31 (4): 1250–1256. http://dx.doi.org/10. 1097/01.CCM.0000050454.01978.3B. PMID: 12682500

14. Bulava G.V., Borovkova N.V., Khvatov V.B., Godkov M.A. Otsenka tyazhesti immunnykh rasstroistv i prognozirovanie razvitiya gnoinosepticheskikh oslozhnenii u patsientov s neotlozhnoi khirurgicheskoi patologiei. [Evaluation of severity of immune disorders and prognosis of the development of pyoseptic complications in patients with emergency surgery pathology]. Vestnik Khirurgii Imeni I.I.Grekova. 2009; 168 (3): 10–16. PMID: 19663272. [In Russ.]

15. Borovkova N.V., Bulava G.V., Ermolov A.S., Khvatov V.B., Abakumov M.M. Sposob otsenki stepeni tyazhesti immunnykh rasstroistv u bolnykh s khirurgicheskimi zabolevaniyami. Patent RF na izobretenie №2314531. [Procedure for estimating the degree of immune disorders in patients with surgical diseases. RF Patent for invention No. 2314531]. [In Russ.]

16. Afifi A., Eizen S. Statistichesky analiz: podkhod s ispolzovaniem EVM. [Statistical analysis: A computeraided approach]. Moscow: Mir; 1982: 488. [In Russ.]

17. Petri A., Sebin K. Naglyadnaya statistika v meditsine. [Visual statisticsin medicine]. Moscow: GEOTARMedia; 2003: 144. [In Russ.]

18. Murphy T.J., Paterson H.M., Mannick J.A., Lederer J.A. Injury, sepsis, and the regulation of Tolllike receptor responses. J. Leukoc. Biol. 2004; 75 (3): 400–407. http://dx.doi.org/10.1189/jlb.0503233. PMID: 14557385

19. Keel M., Trentz O. Pathophysiology of polytrauma. Injury. 2005; 36 (6):691–709. http://dx.doi.org/10.1016/j.injury.2004.12.037. PMID: 15910820

20. Mannick J.A., Rodrick M.L., Lederer J.A. The immunologic response to injury. J. Am. Coll. Surg. 2001; 193 (3): 237–244. http://dx.doi.org/10.1016/S10727515(01)010110. PMID: 11548792

21. Zellweger R., Ayala A., DeMaso C.M., Chaudry I.H. Traumahemor rhage causes prolonged depression in cellular immunity. Shock. 1995; 4 (2): 149–153. http://dx.doi.org/10.1097/00024382199508000 00012. PMID: 7496901

22. Abraham E., Freitas A.A. Hemorrhage produces abnormalities in lymphocyte function and lymphokine generation. J. Immunol. 1989; 142 (3): 899–906. PMID: 2492333

23. Swain S.D., Rohn T.T., Quinn M.T. Neutrophil priming in host defense: role of oxidants as priming agents. Antioxid. Redox Signal. 2002; 4 (1): 69–83. http://dx.doi.org/10.1089/152308602753625870. MID: 11970845

24. Brown G.E., Silver G.M., Reiff J., Allen R.C., Fink M.P. Polymorphonuclear neutrophil chemiluminescence in whole blood from blunt trauma patients with multiple injuries. J. Trauma. 1999; 46 (2): 297–305. http://dx.doi.org/10. 1097/0000537319990200000017. PMID: 10029037

25. Muehlstedt S.G., Richardson C.J., Lyte M., Rodriguez J.L. Systemic and pulmonary effector cell function after injury. Crit. Care Med. 2002; 30 (6): 1322–1326. http://dx.doi.org/10.1097/0000324620020600000029. PMID: 12072689


Review

For citations:


Shabanov A.K., Bulava G.V., Androsova M.V., Kuzovlev A.N., Kislukhina E.V., Khubutia M.Sh. Role of Early Immune Replacement Therapy in Reducing the Rate of Nosocomial Pneumonia in Severe Polytrauma. General Reanimatology. 2014;10(6):15-23. https://doi.org/10.15360/1813-9779-2014-6-15-23

Views: 1285


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1813-9779 (Print)
ISSN 2411-7110 (Online)